IRIS
LARUSSA, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.014
EU - Europa 675
AS - Asia 544
SA - Sud America 54
OC - Oceania 11
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.312
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 959
SG - Singapore 290
IT - Italia 226
DE - Germania 133
CN - Cina 104
GB - Regno Unito 102
FI - Finlandia 66
SE - Svezia 55
BR - Brasile 45
CA - Canada 42
IN - India 40
IR - Iran 38
NL - Olanda 24
TR - Turchia 18
RU - Federazione Russa 11
TW - Taiwan 11
AU - Australia 10
PL - Polonia 10
MX - Messico 8
BD - Bangladesh 7
FR - Francia 7
HK - Hong Kong 7
UA - Ucraina 7
RO - Romania 6
VN - Vietnam 6
ES - Italia 5
EU - Europa 4
ZA - Sudafrica 4
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
IL - Israele 3
IQ - Iraq 3
JP - Giappone 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CH - Svizzera 2
CU - Cuba 2
EG - Egitto 2
HU - Ungheria 2
PK - Pakistan 2
AR - Argentina 1
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
UY - Uruguay 1
Totale 2.312
Salva come PNG Salva come JPEG
Città #
Chandler 152
Singapore 124
Munich 114
Chicago 90
London 86
Santa Clara 81
Lawrence 68
Princeton 68
Milan 66
Helsinki 46
Ashburn 42
Wilmington 41
Ottawa 30
Catanzaro 28
Des Moines 21
Redwood City 19
Mumbai 17
Mendicino 12
Turku 12
Shanghai 11
Beijing 10
Guangzhou 10
São Paulo 10
Istanbul 9
Los Angeles 9
Praia A Mare 9
Boardman 8
Phoenix 8
Rome 8
Collegeville 7
Pune 7
Tehran 7
Cittanova 6
Redmond 6
The Dalles 6
Warsaw 6
Brooklyn 5
Chennai 5
Hanover 5
Hong Kong 5
Jyväskylä 5
Montreal 5
New York 5
Norwalk 5
San Francisco 5
Shenzhen 5
Clearwater 4
Dallas 4
Horia 4
Selargius 4
Taipei 4
Bade District 3
Bari 3
Benevento 3
Boston 3
Bratislava 3
Charlotte 3
Council Bluffs 3
Dhaka 3
Jiaxing 3
Kahramanmaraş 3
Miguel Hidalgo 3
Nanjing 3
Naples 3
Paris 3
Rende 3
Rio de Janeiro 3
Riyadh 3
Wuxi 3
Zabki 3
Ankara 2
Ann Arbor 2
Atlanta 2
Belo Horizonte 2
Buffalo 2
Bungarribee 2
Calumpit 2
Cape Town 2
Capurso 2
Castel Campagnano 2
Chelsea 2
Columbus 2
Esslingen am Neckar 2
Frankfurt am Main 2
Fremont 2
Havana 2
Hefei 2
Ho Chi Minh City 2
Karachi 2
Leuven 2
Lyon 2
Miami 2
Moscow 2
New Taipei City 2
Palermo 2
Pasargad 2
Pécs 2
San Juan 2
San Nicola Manfredi 2
Shenyang 2
Totale 1.441
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 214
Dietary polyphenolsand non-alcoholic fatty liver disease 83
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 61
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 58
The role of gluten-free diet in nonalcoholic fatty liver disease development 57
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 52
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 51
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 50
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 49
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 45
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 45
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 43
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 42
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 42
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 40
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 40
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 39
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 39
Gut microbiota and non-alcoholic fatty liver disease 38
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 37
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 36
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 36
Bone mineralization in celiac disease 35
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 34
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 34
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients 33
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 32
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 31
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 31
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 31
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 30
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 29
Reduced bone mineral density is frequent in treated adult coeliac disease not with standing complete normalization of duodenal lesions. 29
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 29
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 28
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 28
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 28
Crohn disease: Identification, diagnosis, and clinical management. 28
Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease 27
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey 26
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 26
Survey on alcohol consumption in a gastroenetrology outpatient center in southern Italy. 26
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet 25
SURVEY ON ALCOHOL CONSUMPTION IN A GASTROENTEROLOGY OUTPATIENT CENTER IN SOUTHERN ITALY 25
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. 24
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to standard pharmeceutical treatment: a double-blind, randomized, placebo-controlled study 24
Liver Cirrhosis Complications Management At The Emergency Department 24
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. 23
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 22
Epidemiology of Helicobacter pylori infection: the Sorbo San Basile study. 22
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection 22
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 22
High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study 21
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 21
No evidence of circulating autoantibodies against osteoprotegerin in treated celiac patients with low bone mineral density. 20
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 20
Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/Th2 Immune Response in Human Gastric Mucosa 19
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 19
Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study 18
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 18
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 17
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 17
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection 17
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 17
Liver steatosis in celiac disease: the open door 16
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS 16
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 16
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease 15
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis 15
Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir 15
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. 14
From Pre- and Probiotics to Post-Biotics: A Narrative Review. 14
High prevalence of polymorphism and low activity of thiopurine methiltransferase in patients with inflammatory bowel disease. 12
Potential role of nutraceutical compounds in inflammatory bowel disease 11
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 11
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 11
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 11
Totale 2.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021126 0 8 2 16 17 13 10 19 32 7 2 0
2021/2022258 8 7 14 49 17 4 10 48 22 26 37 16
2022/2023610 138 35 48 41 34 36 7 50 55 96 62 8
2023/2024290 69 20 25 16 10 75 6 15 27 2 9 16
2024/2025884 119 45 43 18 70 121 64 42 159 8 73 122
2025/2026132 84 48 0 0 0 0 0 0 0 0 0 0
Totale 2.426